Your session is about to expire
← Back to Search
Adhesion Barrier
SprayShield Adhesion Barrier for Adenomatous Polyposis
N/A
Waitlist Available
Research Sponsored by Integra LifeSciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Diagnosis of ulcerative colitis or familial polyposis and require two-stage surgery for treatment of either of these disorders will be eligibl
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average 10-12 weeks post surgery
Summary
This will be a prospective, multi-center, randomized, single blind study to collect and evaluate post-market clinical data on the SprayShield Adhesion Barrier System as an adjuvant to good surgical technique for the reduction of postoperative adhesion formation following major open abdominal surgery.
Eligible Conditions
- Colitis
- Adenomatous Polyposis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ average 10-12 weeks post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average 10-12 weeks post surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Adhesion Involvement Along the Midline Incision (Percentage)
Mobilization Time
Severity of Adhesions
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: SprayShield Adhesion BarrierExperimental Treatment1 Intervention
SprayShield Adhesion Barrier
Group II: ControlPlacebo Group1 Intervention
Good Surgical Technique Alone
Find a Location
Who is running the clinical trial?
Integra LifeSciences CorporationLead Sponsor
108 Previous Clinical Trials
11,283 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger